Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing epoetin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
epoetin alfa 40.000 IE/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa adverse reaction |
Causative agent |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Allergy to epoetin alfa |
Causative agent |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 2000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 4000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa 2000unt/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa 10000unt/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 4000 enheder/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa 3000unt/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa 20000unt/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa 2000unt/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa 3000unt/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa 4000unt/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa 10000unt/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Epoetin alfa 20000unt/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 40.000 enheder/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,9 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,7 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
humant albumin 2,5 mg + epoetin alfa 20.000 IE injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 3000 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 20.000 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 10.000 enheder/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 2000 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
epoetin alfa 4000 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
|
Allergy to epoetin alfa |
Causative agent |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 5000 unit/0.5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 5000 unit/0.5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 3000 unit/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 3000 unit/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 4000 unit/0.4 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 4000 unit/0.4 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 7000 unit/0.7 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 7000 unit/0.7 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 6000 unit/0.6 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 6000 unit/0.6 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 8000 unit/0.8 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 8000 unit/0.8 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 9000 unit/0.9 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 9000 unit/0.9 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 1000 unit/0.5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 1000 unit/0.5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 40000 unit/1 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 40000 unit/1 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 2000 unit/0.5 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 2000 unit/0.5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing only epoetin alfa in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa 2000 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa 2000 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa 40000 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa 40000 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa 4000 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa 4000 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa 20000 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |
Epoetin alfa 20000 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoetin alfa (substance) |
Inferred relationship |
Some |
1 |